Sign In
Buy CERT
$8.10
+0.320 (+4.11%)
At Close: Jul 31, 2026
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst
03:23pm, Wednesday, 22'nd Apr 2026
Certara Inc. (NASDAQ:CERT) shares are up 2.34% on Wednesday as the company announced it has entered into a definitive agreement to sell its Regulatory and Medical Writing business.
Veristat to Acquire Certara's Regulatory and Medical Writing Business
07:00am, Wednesday, 22'nd Apr 2026
SOUTHBOROUGH, Mass.--(BUSINESS WIRE)-- #Biotech--Veristat (the “Company”), a science-first full-service CRO and consultancy that advances complex therapies through the drug development lifecycle t
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
07:00am, Wednesday, 22'nd Apr 2026
Transaction sharpens focus on Model-Informed Drug Development (MIDD) and Clinical Intelligence Updated 2026 guidance to be provided upon transaction close RADNOR, Pa., April 22, 2026 (GLOBE NEWSWIRE
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
04:15pm, Thursday, 09'th Apr 2026
RADNOR, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the first q
Certara, Inc. (NASDAQ:CERT) Given Consensus Recommendation of “Hold” by Analysts
04:43am, Friday, 03'rd Apr 2026
Certara, Inc. (NASDAQ: CERT - Get Free Report) has received an average rating of "Hold" from the fourteen analysts that are covering the firm, MarketBeat Ratings reports. One investment analyst has ra
Cerrado Gold Inc. (CERT:CA) Q4 2025 Earnings Call Transcript
04:12pm, Thursday, 02'nd Apr 2026
Cerrado Gold Inc. (CERT:CA) Q4 2025 Earnings Call Transcript
Brown Brothers Harriman & Co. Has $46 Million Holdings in Certara, Inc. $CERT
04:38am, Saturday, 14'th Mar 2026
Brown Brothers Harriman and Co. boosted its holdings in shares of Certara, Inc. (NASDAQ: CERT) by 34.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchan
Certara, Inc. $CERT Shares Sold by 2Xideas AG
03:49am, Saturday, 14'th Mar 2026
2Xideas AG trimmed its holdings in shares of Certara, Inc. (NASDAQ: CERT) by 41.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 184,198 shares of
Alpha Wave Global LP Takes Position in Certara, Inc. $CERT
03:05am, Saturday, 14'th Mar 2026
Alpha Wave Global LP acquired a new position in Certara, Inc. (NASDAQ: CERT) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. T
Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
03:20pm, Tuesday, 10'th Mar 2026
Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript
10:28am, Monday, 09'th Mar 2026
Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference
02:34am, Monday, 09'th Mar 2026
Certara (NASDAQ: CERT) executives used a fireside chat at the TD Cowen Health Care Conference to outline early priorities under new CEO Jon Resnick, discuss the company's ongoing strategic review of i
Certara, Inc. (CERT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
06:12pm, Tuesday, 03'rd Mar 2026
Certara, Inc. (CERT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
08:00am, Tuesday, 03'rd Mar 2026
RADNOR, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based p
Touchstone Small Cap Fund Q4 2025 Portfolio Review
07:20am, Monday, 02'nd Mar 2026
The Touchstone Small Cap Fund (Class A Shares, Load Waived) outperformed its benchmark, the Russell 2000® Index, for the quarter ended December 31, 2025. The best performing stocks based on relative
